Impact of disease modifying therapy on fatigue among multiple sclerosis patients

被引：0
|
作者：
Elkhooly, Mahmoud [1 ,2 ]
Raghib, Muhammad [1 ]
Lazar, Emily [1 ]
Lazar, Adam [1 ]
Liaquat, Zaima [1 ]
Martinez, Carla [1 ]
Rube, Jacob [1 ]
Bernitsas, Evanthia [1 ]
机构：
[1] Wayne State Univ, Neurol, Detroit, MI USA
[2] Minia Univ, Neurol & Psychiat, Al Minya, Egypt
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1620/2035
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [21] Time to relapse among propensity score matched patients receiving disease modifying therapy for multiple sclerosis
    Johnson, B. H.
    Bonafede, M. M.
    Watson, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 202 - 203
  • [22] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [23] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [24] Variables affecting disease modifying therapy adherence and impact of adherence on multiple sclerosis patients (Egyptian experience)
    Abdelsalam, A.
    Elkabany, R.
    Alahmar, I.
    Elkholy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 802 - 803
  • [25] Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
    Molazadeh, Negar
    Sahraian, Mohammad Ali
    Ghajarzadeh, Mahsa
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 89 - 93
  • [26] No association between disease modifying treatment and fatigue in multiple sclerosis
    Broch, Line
    Flemmen, Heidi Oyen
    Simonsen, Cecilia Smith
    Berg-Hansen, Pal
    Ormstad, Heidi
    Brunborg, Cathrine
    Celius, Elisabeth Gulowsen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [27] Comorbid anxiety, depression, and fatigue symptoms by disease modifying therapy: a national multiple sclerosis cohort
    Maldonado, D. Pimentel
    Hemond, C.
    Eusebio, J.
    Umeton, R.
    Morales, I. Berrios
    Mowry, E.
    Ionete, C.
    Fitzgerald, K.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 332 - 332
  • [28] PRIOR DISEASE-MODIFYING DRUG USE AMONG PATIENTS WITH MULTIPLE SCLEROSIS
    Phillips, A. L.
    Kozma, C. M.
    Lorenzo, R.
    Locklear, J.
    VALUE IN HEALTH, 2014, 17 (03) : A67 - A67
  • [29] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
    Erin E. Longbrake
    Becky J. Parks
    Anne H. Cross
    Current Neurology and Neuroscience Reports, 2013, 13
  • [30] Prevalence of Treatment Interruptions for Disease Modifying Therapies among Patients with Multiple Sclerosis
    Lublin, F. D.
    Rossi, C.
    Le, H. H.
    Holiday, C.
    Lefebvre, P.
    Pilon, D.
    Keenan, A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 201 - 202
12345